Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000891293-16-000079)

Filing Details

Accession Number:: 0000891293-16-000079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-06 17:57:05
Reporting Period:: 2016-01-04

Filing Date:: 2016-01-06
Accepted Time:: 2016-01-06 17:57:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cti Biopharma Corp	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557551	Matthew Plunkett	3101 Western Avenue, Suite 600 Seattle WA 98121	Evp, Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-01-04	1,600	$1.20	618,484	No	4	S	Direct
Common Stock	Disposition	2016-01-04	1,898	$1.20	616,586	No	4	S	Direct
Common Stock	Disposition	2016-01-04	800	$1.21	615,786	No	4	S	Direct
Common Stock	Disposition	2016-01-04	1,900	$1.21	613,886	No	4	S	Direct
Common Stock	Disposition	2016-01-04	1,700	$1.22	612,186	No	4	S	Direct
Common Stock	Disposition	2016-01-04	800	$1.23	611,386	No	4	S	Direct
Common Stock	Disposition	2016-01-04	300	$1.24	611,086	No	4	S	Direct
Common Stock	Disposition	2016-01-04	202	$1.24	610,884	No	4	S	Direct
Common Stock	Disposition	2016-01-04	600	$1.25	610,284	No	4	S	Direct
Common Stock	Disposition	2016-01-04	200	$1.26	610,084	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale was effected pursuant to a Rule 10b5-1 trading plan.